Bank of New York Mellon Corp

Bank

Position in GYRE — Gyre Therapeutics, Inc.

CIK 1390777 NEW YORK, NY

Position in GYRE

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$413,521

+$112,809 QoQ

Shares Held

62,750

+45.4% QoQ

Ownership

0.056%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#13

of 60 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 96% Shared 0% None 4%

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,844,643,771 across 310 Biotechnology names. GYRE ranks #255 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,672,623	$830,842,010
2	REGN	Regeneron Pharmaceuticals, Inc.	758,492	$472,950,091
3	JAZZ	Jazz Pharmaceuticals plc	1,578,013	$380,253,782
4	ALNY	Alnylam Pharmaceuticals, Inc.	492,071	$148,128,128
5	INSM	INSMED Inc	1,312,756	$139,966,036
6	MRNA	Moderna, Inc.	1,701,675	$119,168,293
7	RVMD	Revolution Medicines, Inc.	601,056	$112,565,759
8	INCY	Incyte Corp	972,825	$110,279,435

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$413,521	62,750	+45.4%	Shares	Defined	2026-08-06
2026-03-31	$300,712	43,144	+4.7%	Shares	Defined	2026-05-05
2025-12-31	$290,892	41,203	+68.9%	Shares	Defined	2026-02-10
2025-09-30	$182,008	24,398	+1.7%	Shares	Defined	2025-11-03
2025-06-30	$176,318	23,989	+45.5%	Shares	Defined	2025-08-05
2025-03-31	$127,317	16,492	+18.7%	Shares	Defined	2025-04-29
2024-12-31	$168,141	13,896	+11.1%	Shares	Defined	2025-02-04
2024-09-30	$156,837	12,507	-31.5%	Shares	Defined	2024-11-12
2024-06-30	$217,912	18,266	—	Shares	Defined	2024-07-25
No filing history on record for this holder in this stock.